logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Latest

Lates News

date
18/06/2025
Morgan Stanley: Capital is flowing out of the United States, and Latin American stocks are expected to receive $66 billion in capital inflows, accounting for approximately 6% of their current market value.
Latest
3 m ago
International oil prices continue to strengthen, with WTI crude oil rising by 5%.
6 m ago
Raw sugar futures fell around 3.1%, while Arabica coffee futures fell more than 2.6%.
7 m ago
Los Angeles Mayor BASS lifts the curfew in Downtown Los Angeles.
9 m ago
The U.S. Food and Drug Administration (FDA) announced a new "National Priority Voucher Program" aimed at shortening the drug review time for companies that it deems to support national interests to one to two months. On June 17th, the FDA stated that the National Priority Voucher Program aims to significantly reduce the drug review time from the current average of 10-12 months. The FDA stated that in the first year of the program, they plan to issue a limited number of vouchers to companies that meet the criteria of "U.S. National Priority."
9 m ago
The FDA announced a new program to shorten drug review times to two months.
See all latestmore
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2025 GMT EIGHT Holdings. All Rights Reserved.